NEWS PROVIDED BY Bluegrass Vascular Technologies – 24 Apr, 2017, 07:00 ET SAN ANTONIO, April 24, 2017 /PRNewswire/ — Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today that it has successfully enrolled over one third of its […]
Author: Ken Dropiewski
SIRT is better tolerated than sorafenib, but doesn’t increase overall survival in HCC
PUBLIC RELEASE: 22-APR-2017 April 22, 2017, Amsterdam, The Netherlands: Results of the SARAH trial presented today demonstrate that SIRT resulted in median overall survival (OS) of 8.0 months compared to 9.9 months with sorafenib (p=0.179), in patients with locally advanced and inoperable hepatocellular carcinoma (HCC). The trial, presented at The International […]
MRI Interventions (MRIC) Release: Publication Provides Guidelines To Reduce Transportation Risks Associated With Neurosurgical Laser Ablation Multi-Site Workflows
IRVINE, Calif., April 24, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced that the reduced patient risk associated with a One-Room, One-Procedure workflow for laser ablation has been reviewed in the journal of the American Society for Healthcare Risk Management (AHRM) April issue. The findings indicate a one […]
Lombard Medical Appoints New CEO
April 20, 2017 02:25 PM Eastern Daylight Time OXFORDSHIRE, England–(BUSINESS WIRE)–Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Kurt Lemvigh has been appointed as its new Chief Executive Officer, effective immediately. Lemvigh is a veteran medical device executive with […]
Getinge launches the new Advanta V12 – 32mm Balloon Expandable Covered Stent
Press release: Maquet Getinge Group 2017-04-21 Getinge is proud to announce the launch of the Advanta™ V12™ 32mm length* balloon expandable covered stent at Charing Cross International Congress. This is a much needed addition to the Advanta™ V12™ product offering and will allow clinicians additional treatment options for optimal patient […]
Cardiac Insight Announces FDA Clearance of “CARDEA SOLO™” – The First Wearable (ECG) Sensor Giving Physicians Immediate Access to Complete Cardiac Arrhythmia Data and Analysis
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, a U.S. developer of body worn sensing devices and computational software, announced today, the FDA has cleared the company’s wearable electrocardiogram (ECG) sensor, CARDEA SOLO™. The device offers physicians immediate access to improved reporting and analysis of heartbeat-to-heartbeat data. The design and ease of use also […]
First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting Beads
NEWS PROVIDED BY BTG Plc – 20 Apr, 2017, 02:00 ET LONDON, April 20, 2017 /PRNewswire/ — BTG plc (LSE: BTG), a global specialist healthcare company, today announced the treatment of the first patients in the EU with DC Bead LUMI™. Two patients were treated for hepatocellular carcinoma (HCC) and one […]
Lessons We Can Learn From the Abbott BVS Data
By Ken Dropkiewski The bioresorbable stent was approved for use by the FDA in July of 2016. The Absorb GT1 Bioresorbable Vascular Scaffold System, manufactured by Abbott, was all set to solve a litany of the problems inherent with conventional cardiac and vascular stents. Conventional stents, made of flexible metal […]
Medical Groups Unite in Support of Science
NEWS PROVIDED BY American Society of Hematology 17 Apr, 2017, 08:38 ET WASHINGTON, April 17, 2017 /PRNewswire-USNewswire/ — As the world’s leading organizations representing clinicians, laboratory researchers, and physician-scientists committed to improving patient care, we support the March for Science and its nonpartisan call for the appreciation of scientific evidence, education, and investment. Science […]
Lombard Medical’s CEO Steps Down
OXFORDSHIRE, England–(BUSINESS WIRE)–Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Simon Hubbert has stepped down from his position as CEO on April 18 after serving in the role for more than six years. A search is underway for a […]



